Cell Genesys Inc. fell short in winning shareholder approval for its $38 million merger with BioSante Pharmaceuticals but will try again Oct. 14. (CEGE) (BPAX)
This entry was posted
on Friday, October 2nd, 2009 at 9:22 pm and is filed under Uncategorized.
You can follow any responses to this entry through the RSS 2.0 feed.
Both comments and pings are currently closed.